At week 56 in the OB-202 / DM-230 , change in weight ( from intent-to-treat sample with last observation carried forward [ ITT-LOCF ] ) was -2.7 % for placebo and -9.4 % for PHEN/TPM ER 15/92 ( P < 0.0001 vs. placebo ) .